Single-Cell Multi-Omics Integration to Find Blood Targets for Brain Diseases

June 04, 2026
Multi-Omics Integration Stage
  • Harnessing single-cell multi-omics to pinpoint potential therapeutic targets for brain diseases. 
  • Integrating transcriptomic and epigenomic data to reveal cellular heterogeneity and disease-relevant pathways. 
  • Deep-learning model suggests potential drug repurposing candidates.
Speakers
Mark Gerstein
Mark Gerstein, Professor of Biomedical Informatics - Yale School of Medicine